Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2025-12-24 @ 7:00 PM
NCT ID:
NCT05266157
Eligibility Criteria:
Inclusion Criteria:
* Patients included in the prospective observational study and developing lymphoedema within the first year after surgery
* Before inclusion, written informed consent must be given according to ICH/GCP, and national/local regulations.
Inclusion criteria of the prospective observational study were:
* Non-metastatic urogenital cancer (i.e. prostate cancer or bladder cancer)
* Pelvic lymph node dissection
Exclusion Criteria: same as for the prospective observational study:
* Radiological evidence of metastatic disease based on pelvic CT/MRI and bone scan
* Clinical signs of chronic venous insufficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05266157
Study Brief:
Protocol Section:
NCT05266157